ANO1 and cancer: Moreover, the pharmacological inhibition of ANO1 using diethylstilbestrol, luteolin, and other inhibitors affects both its channel function and protein levels and thus suppresses cancer cell proliferation and migration (Seo et al., 2017; 2021).